Letters to Officials
CCAGW Urges Senate Homeland Security and Government Affairs Committee to Support S. 2871
S. 2871 would make federal agencies more secure and efficient while reducing costs and duplication.
CCAGW Urges House Oversight Committee to Support H.R. 262
The ALERT Act would bring more accountability and transparency to the regulatory process.
CAGW Joins Coalition Opposing Cuts to Medicare Advantage Program
Medicare Advantage is provided through private plans rather than government-run plans and allows private companies to compete.
CAGW Joins Coalition Opposing Cuts to Medicare Advantage Program
Medicare Advantage is provided through private plans rather than government-run plans and allows private companies to compete.
CCAGW Urges House Oversight Committee to Support H.R. 262
The ALERT Act would bring more accountability and transparency to the regulatory process.
CCAGW Urges House Oversight Committee to Oppose H.R. 6283
H.R. 6283 would impose unnecessary and harmful regulations on PBMs that will lead to higher prices and fewer options.
CCAGW Urges Kentucky Legislators to Oppose Senate Bill 27
SB 27 would change how the federal 340B program operates in the Commonwealth of Kentucky.
CCAGW Urges Florida Legislators to Oppose House Bill 1431
This legislation threatens drug innovation and development in the U.S. and will lead to fewer future cures.
CCAGW Urges West Virginia Legislators to Oppose Senate Bill 325
SB 325 would make changes to the federal 340B drug discount program.
CCAGW Joins Coalition Supporting H.R. 5779, The Fiscal Commission Act of 2023
A fiscal commission would take steps to put the nation back on the right fiscal track.
CCAGW Joins Coalition Opposing Biden's Surrender on Digital Trade
Congress and the White House should support America's leading and most innovative industry.
CCAGW Urges House of Representatives to Support H.J. Res. 98
Lawmakers should overturn the NLRB's burdensome new regulation and enact pro-growth policies that will help the economy.